In line with our results, other authors have previously demonstrated that stimulation with IL-15 enhanced the cytotoxicity of NK cells against K562 targets, primary acute leukemic blasts, and rhabdomyosarcoma cell lines (67–70). Here, IL15 is linked to rhabdomyosarcoma.